Afficher la notice abrégée

dc.contributor.authorAguilera-Garrido, Aixa
dc.contributor.authorCastillo Santaella, Teresa del 
dc.contributor.authorYang, Yan
dc.contributor.authorGalisteo-González, Francisco 
dc.contributor.authorGálvez-Ruiz, María José 
dc.contributor.authorMolina Bolívar, José Antonio
dc.contributor.authorHolgado-Terriza, Juan Antonio 
dc.contributor.authorCabrerizo-Vílchez, Miguel Ángel 
dc.contributor.authorMaldonado-Valderrama, Julia 
dc.date.accessioned2024-01-25T13:30:06Z
dc.date.available2024-01-25T13:30:06Z
dc.date.issued2021-01-20
dc.identifier.citationAdvances in Colloid and Interface Science 290 (2021) 102365-102381es_ES
dc.identifier.urihttps://hdl.handle.net/10481/87313
dc.description.abstractOne of the major applications of SerumAlbumins is their use as delivery systems for lipophilic compounds in biomedicine. Their biomedical application is based on the similarity with Human Serum Albumin (HSA), as a fully biocompatible protein. In general, Bovine Serum Albumin (BSA) is treated as comparable to its human homologue and used as a model protein for fundamental studies since it is available in high amounts and well understood. This protein can act as a carrier for lipophilic compounds or as protective shell in an emulsion-based vehicle. Polysaccharides are generally included in these formulations in order to increase the stability and/or applicability of the carrier. In this review, themain biomedical applications of Albumins as drug delivery systems are first presented. Secondly, the differences between BSA andHSA are highlighted, exploring the similarities and differences between these proteins and their interaction with polysaccharides, both in solution and adsorbed at interfaces. Finally, the use of Albumins as emulsifiers for emulsion-based delivery systems, concretely as Liquid Lipid Nanocapsules (LLNs), is revised and discussed in terms of the differences encountered in the molecular structure and in the interfacial properties. The specific case of Hyaluronic Acid is considered as a promising additivewith important applications in biomedicine. The literatureworks are thoroughly discussed highlighting similarities and differences between BSA and HSA and their interaction with polysaccharides encountered at different structural levels, hence providing routes to control the optimal design of delivery systems.es_ES
dc.description.sponsorshipThis work has been funded by the following projects, which are gratefully acknowledged: MAT2017-82182-R and RTI2018-101309-BC21 (Ministerio de Ciencia e Innovación). The authors also acknowledge “Mancomunidad de los Pueblos de la Alpujarra Granadina” for the funds raised and supplied for this research.es_ES
dc.language.isoenges_ES
dc.publisherElsevier B.V.es_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleApplications of serum albumins in delivery systems: Differences in interfacial behaviour and interacting abilities with polysaccharideses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doihttps://doi.org/10.1016/j.cis.2021.102365
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional